Symbol: |
FRAS1
|
Description: |
Fraser syndrome 1 [Source:HGNC Symbol;Acc:19185]
|
Location: |
Chr4:78978724-79465423[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:116
Gene |
Compound |
Gen_sig |
Exp_pattern |
FRAS1 |
NSC 106723 |
0.005 |
Down |
FRAS1 |
NSC 112789 |
0.029 |
Up |
FRAS1 |
NSC 11865 |
0.019 |
Down |
FRAS1 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.027 |
Down |
FRAS1 |
NSC 148201 |
0.049 |
Down |
FRAS1 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.011 |
Down |
FRAS1 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.033 |
Down |
FRAS1 |
NSC 23416 |
0.001 |
Down |
FRAS1 |
NSC 26669 |
0.013 |
Up |
FRAS1 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.006 |
Down |
FRAS1 |
ANTINEOPLASTIC-328785 |
0.027 |
Down |
FRAS1 |
ANTINEOPLASTIC-376265 |
0.01 |
Down |
FRAS1 |
Morpholine-N-dithiocarbamate |
0.014 |
Down |
FRAS1 |
9,10-o-Benzenoanthracene-1,4-dione, 2,3-dichloro-9,10-dihydro- |
0.046 |
Up |
FRAS1 |
NSC 50567 |
0.026 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:68
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
|